Karo Healthcare AB - Company Profile
Powered by 
All the sales intelligence you need on Karo Healthcare AB in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Karo Healthcare AB fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Karo Healthcare AB.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Karo Healthcare AB (Karo), formerly Karo Pharma AB, is a healthcare company. It specializes in branded medicines across key healthcare categories, including skin health, foot health, intimate health, digestive health, and vitamins & mineral supplements (VMS). Its portfolio features brands like E45, Locobase, Remescar, Pevaryl, Lamisil, Nutravita, Alpha Foods, and Lactocare among others. Karo’s products address common health issues such as dry skin, fungal infections, digestive discomfort, and foot care. The company operates primarily in Europe and the Nordic region. Karo is headquartered in, Stockholm, Sweden.
Headquarters
Sweden
Address
Klara Norra Kyrkogata 33, Stockholm, 11122
Website
www.karopharma.se
Telephone
46 8 4443820
No of Employees
460
Industry
Pharmaceuticals and Healthcare
Revenue (2024)
$563.6M
Karo Healthcare AB premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Therapy Areas: | Allevo |
| Skin Health | Alpha Foods |
| Intimate Health | Apobase |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Plans/Strategy | In April, the company announced its plans to be acquired by KKR. |
| 2024 | Acquisitions/Mergers/Takeovers | In March, the company acquired Proctosedyl from Bayer. |
| 2023 | Acquisitions/Mergers/Takeovers | In November, the company completed the acquisition of Global OTC brand Lamisil from Haleon UK Holdings Ltd. |
Competitor Comparison
| Key Parameters | Karo Healthcare AB | Kenvue Inc | Haleon Plc | Stada Arzneimittel AG | Active Biotech AB |
|---|---|---|---|---|---|
| Headquarters | Sweden | United States of America | United Kingdom | Germany | Sweden |
| City | Stockholm | Skillman | Weybridge | Bad Vilbel | Lund |
| State/Province | - | New Jersey | - | Hessen | - |
| No. of Employees | 460 | 21,780 | 24,561 | 11,649 | 5 |
| Entity Type | Private | Public | Public | Private | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Christoffer Lorenzen | Chief Executive Officer | Senior Management | 2019 | - |
| Karine Martin | Chief Financial Officer | Senior Management | 2026 | - |
| Jonathan Kimber | Chief Operating Officer | Senior Management | 2019 | - |
| Sally Perry | Chief Marketing Officer | Senior Management | 2022 | - |
| Konstanze Gallinatus | Chief Transformation Officer | Senior Management | 2026 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer